The LIA and ELISA have good agreement in detecting aPL in APS, but the LIA differentiates patients with APS from infectious patients and asymptomatic carriers, likely through the exposure of domain 1. This evidence concerns the gene FASLG and autoimmune polyendocrinopathy.